Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)

Maggie Tabberer; C. Elaine Jones; Sally Kilbride; David M.G. Halpin; David A. Lomas; Steven Pascoe; Dave Singh; Robert A. Wise; Gerard J. Criner; Peter Lange; Mark T. Dransfield; Mei Lan K. Han; Fernando J. Martinez; Morrys C. Kaisermann; David A. Lipson

doi:10.1007/s12325-021-02019-8

Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)

Maggie Tabberer, C. Elaine Jones, Sally Kilbride, David M.G. Halpin, David A. Lomas, Steven Pascoe, Dave Singh, Robert A. Wise, Gerard J. Criner, Peter Lange, Mark T. Dransfield, Mei Lan K. Han, Fernando J. Martinez, Morrys C. Kaisermann, David A. Lipson

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original article the disclosures for the author MeiLan K. Han are missing. MeiLan K. Han’s disclosures should read as “MeiLan K. Han has received personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck and Mylan. Research support was also received from Novartis and Sunovion”.

Original language	English (US)
Pages (from-to)	1446
Number of pages	1
Journal	Advances in Therapy
Volume	39
Issue number	3
DOIs	https://doi.org/10.1007/s12325-021-02019-8
State	Published - Mar 2022

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1007/s12325-021-02019-8

Cite this

Tabberer, M., Jones, C. E., Kilbride, S., Halpin, D. M. G., Lomas, D. A., Pascoe, S., Singh, D., Wise, R. A., Criner, G. J., Lange, P., Dransfield, M. T., Han, M. L. K., Martinez, F. J., Kaisermann, M. C., & Lipson, D. A. (2022). Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8). Advances in Therapy, 39(3), 1446. https://doi.org/10.1007/s12325-021-02019-8

Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8). / Tabberer, Maggie; Jones, C. Elaine; Kilbride, Sally et al.
In: Advances in Therapy, Vol. 39, No. 3, 03.2022, p. 1446.

Research output: Contribution to journal › Comment/debate › peer-review

Tabberer, M, Jones, CE, Kilbride, S, Halpin, DMG, Lomas, DA, Pascoe, S, Singh, D, Wise, RA, Criner, GJ, Lange, P, Dransfield, MT, Han, MLK, Martinez, FJ, Kaisermann, MC & Lipson, DA 2022, 'Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)', Advances in Therapy, vol. 39, no. 3, pp. 1446. https://doi.org/10.1007/s12325-021-02019-8

@article{e5e38e9d9e5b474d823d7dc1e06d1c74,

title = "Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)",

abstract = "In the original article the disclosures for the author MeiLan K. Han are missing. MeiLan K. Han{\textquoteright}s disclosures should read as “MeiLan K. Han has received personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck and Mylan. Research support was also received from Novartis and Sunovion”.",

author = "Maggie Tabberer and Jones, {C. Elaine} and Sally Kilbride and Halpin, {David M.G.} and Lomas, {David A.} and Steven Pascoe and Dave Singh and Wise, {Robert A.} and Criner, {Gerard J.} and Peter Lange and Dransfield, {Mark T.} and Han, {Mei Lan K.} and Martinez, {Fernando J.} and Kaisermann, {Morrys C.} and Lipson, {David A.}",

note = "Publisher Copyright: {\textcopyright} Springer Healthcare Ltd., part of Springer Nature 2022.",

year = "2022",

month = mar,

doi = "10.1007/s12325-021-02019-8",

language = "English (US)",

volume = "39",

pages = "1446",

journal = "Advances in Therapy",

issn = "0741-238X",

publisher = "Health Communications Inc.",

number = "3",

}

TY - JOUR

T1 - Correction to

T2 - Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)

AU - Tabberer, Maggie

AU - Jones, C. Elaine

AU - Kilbride, Sally

AU - Halpin, David M.G.

AU - Lomas, David A.

AU - Pascoe, Steven

AU - Singh, Dave

AU - Wise, Robert A.

AU - Criner, Gerard J.

AU - Lange, Peter

AU - Dransfield, Mark T.

AU - Han, Mei Lan K.

AU - Martinez, Fernando J.

AU - Kaisermann, Morrys C.

AU - Lipson, David A.

PY - 2022/3

Y1 - 2022/3

N2 - In the original article the disclosures for the author MeiLan K. Han are missing. MeiLan K. Han’s disclosures should read as “MeiLan K. Han has received personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck and Mylan. Research support was also received from Novartis and Sunovion”.

AB - In the original article the disclosures for the author MeiLan K. Han are missing. MeiLan K. Han’s disclosures should read as “MeiLan K. Han has received personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck and Mylan. Research support was also received from Novartis and Sunovion”.

UR - http://www.scopus.com/inward/record.url?scp=85123216954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123216954&partnerID=8YFLogxK

U2 - 10.1007/s12325-021-02019-8

DO - 10.1007/s12325-021-02019-8

M3 - Comment/debate

C2 - 35060093

AN - SCOPUS:85123216954

SN - 0741-238X

VL - 39

SP - 1446

JO - Advances in Therapy

JF - Advances in Therapy

IS - 3

ER -

Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this